Companies probe Merck for foreign anti-bribery law violations Merck, the second biggest international drug maker, has been investigated by two U.S. The Section of Justice and the Securities and Exchange Commission are both looking for information about Merck activities that may violate the Foreign Corrupt Methods Take action, which, among other activities, prohibits U read more .S.-centered companies from bribing officials far away. Merck says it has in place an FCPA compliance program, and our plan is to carry out our business relative to all applicable laws .
Related StoriesStudy shows uncommon HER2 missense mutations do not spread breast cancer on the ownMeat-rich diet may boost kidney cancers riskFDA grants accelerated acceptance for Tagrisso to treat patients with advanced NSCLCAgendia joins the FDA among other leading businesses, including Genentech, the College of American Pathologists, and the Genetics & Public Policy Center at Johns Hopkins University, in contacting for a tiered risk-based approach to the regulation of LDTs. As the country’s leading authority for patient basic safety, Agendia believes that only the FDA can regulate the LDT category in a uniform and unbiased way to ensure that all statements are validated, data is normally accurate and post-market surveillance is in place.